Key result
Cisapride administration induced a transient increase in plasma aldosterone levels on day 1 that returned to placebo-treated values within 10 hours, with no effect on days 2 and 3.
Why the study?
Does prolonged oral administration of cisapride affect aldosterone secretion in healthy volunteers?
RCT (n=12)
Single-blind
Does prolonged oral administration of cisapride affect aldosterone secretion in healthy volunteers?
Prolonged administration of the 5-HT4 agonist cisapride causes only a transient increase in aldosterone secretion due to rapid receptor desensitization, explaining the lack of hypertensive effects during chronic treatment.
Answers are grounded in this paper and cite their sources.
Supports transient aldosterone effects only with initial cisapride dosing; leaves open applicability to other 5-HT4 agonists or patient populations.
In man, serotonin (5-HT) has been shown to stimulate aldosterone secretion through activation of 5-HT4 receptors, In particular, we have observed that oral administration of a single dose of the 5-HT4 receptor agonist cisapride (10 mg) induces a 5-fold increase in plasma aldosterone levels in healthy volunteers. Surprisingly, the usual disorders associated with hyperaldosteronism, i.e. hypertension and hypokalemia, have never been reported during chronic treatment with cisapride. In the present study, we have investigated the effect of prolonged oral administration of cisapride (10 mg, 3 times/day during 7 days) on aldosterone secretion in 12 healthy volunteers, in a simple blind fashion versus placebo. On day 1 of the treatment, cisapride induced a significant increase in plasma aldosterone levels (PAL) which returned to the values observed after placebo treatment within 10 hrs. On days 2 and 3, PAL were similar in cisapride- and placebo-treated subjects. Urinary aldosterone, kalemia and reninemia were not influenced by cisapride during the 7 days of the treatment. The present study shows that cisapride only exerts a transient stimulatory effect on aldosterone secretion in healthy volunteers. These data explain why long-term administration of 5-HT4 agonists does not affect blood pressure in man. They also indicate that prolonged stimulation of adrenal 5-HT4 receptors in vivo yields to a rapid desensitization phenomenon, as previously observed in vitro.
No takes yet. Share an insight, caveat, or question.
Lefèbvre et al. (1998) conducted an RCT in Healthy volunteers (n=12). Cisapride vs. Placebo was evaluated on Plasma aldosterone levels. Cisapride administration induced a transient increase in plasma aldosterone levels on day 1 that returned to placebo-treated values within 10 hours, with no effect on days 2 and 3.
Synapse has enriched 10 related papers. Consider them for comparative context: